Cline Scientific AB (OSTO:CLINE B) Beta: -0.1644 (As of Jun. 30, 2026)


OSTO:CLINE B Cline Scientific AB OSTO:CLINE B
4 GF Score
Price kr0.07
View Full Analysis

What is Cline Scientific AB Beta?

Cline Scientific AB OSTO:CLINE B 4 Beta is -0.1644 as of Jun. 30, 2026. GuruFocus rates OSTO:CLINE B with a GF Score™ of 4/100.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-30), Cline Scientific AB's Beta is -0.1644.


Cline Scientific AB  (OSTO:CLINE B) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Cline Scientific AB Beta Related Terms


Cline Scientific AB Beta Historical Data

* Premium members only.

The historical data trend for Cline Scientific AB's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cline Scientific AB Beta Chart

Cline Scientific AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beta
Get a 7-Day Free Trial Premium Member Only -0.42 -0.06 0.03 0.44 0.55

Cline Scientific AB Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.69 0.44 0.47 0.55

OSTO:CLINE B vs VRTX, REGN, SGEN: Beta Comparison

For the Biotechnology subindustry, Cline Scientific AB's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cline Scientific AB Beta vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cline Scientific AB's Beta distribution charts can be found below:

* The bar in red indicates where Cline Scientific AB's Beta falls into.


OSTO:CLINE B
4GF Score
Cline Scientific AB OSTO:CLINE B
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cline Scientific AB Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of -0.1644 mean?
Cline Scientific AB (OSTO:CLINE B) has a Beta of -0.1644 as of Jun. 30, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Cline Scientific AB and its competitors.
Is Cline Scientific AB's Beta too high?
Cline Scientific AB's current Beta is -0.1644. Overall, Cline Scientific AB has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Cline Scientific AB's Beta compare to VRTX and REGN?
Cline Scientific AB's Beta of -0.1644 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Biotechnology company?
A good Beta depends on the Biotechnology industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Cline Scientific AB and its competitors. Cline Scientific AB's current Beta is -0.1644. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cline Scientific AB stock overvalued right now?
Cline Scientific AB (OSTO:CLINE B) has a current Beta of -0.1644. The current Beta is -0.1644. Cline Scientific AB's overall GF Score™ is 4/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Cline Scientific AB (OSTO:CLINE B), the current Beta is -0.1644 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cline Scientific AB Business Description

Address Vastra Gotalands Lan, 2C Argongatan, Molndal, SWE, 43153
Cline Scientific AB develops and markets products for biomedical research based on proprietary nanotechnology. Its products include unique surfaces for use in stem cell & cancer research and customized nanoparticles for use in biomedical applications.
4GF Score

Get the complete analysis for OSTO:CLINE B

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.07
Price